TITLE

Mercado al alza

PUB. DATE
September 2006
SOURCE
Entrepreneur Mexico;sep2006, Vol. 14 Issue 9, p32
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
22936429

 

Related Articles

  • AHN's president makes hefty donation to Rev. Al's campaign.  // New York Amsterdam News;04/05/97, Vol. 88 Issue 14, p31 

    Reports on Frank Mercado-Valdez, president of the African Heritage Movie Network donated of $7,700 to Reverend Al Sharpton's New York mayoral campaign. Comments from both Sharpton and Mercado-Valdes.

  • An Avalanche of Alliances. Hallahan, Mary // Pharmaceutical Executive;Jun2000, Vol. 20 Issue 6, p136 

    Focuses on the agreements entered by Alza company with other pharmaceutical companies. Marketing agreements of Alza with Bayer for the drugs Avalox and CiproR; Partnership of Alza with McNeil Health to copromote Concerta; Benefits of the alliances to Alza.

  • Role of cholestyramine in the treatment of hyperthyroidism. Luccarelli, Melissa E. // American Family Physician;2/1/1997, Vol. 55 Issue 2, p663 

    Presents a summary of an article titled `Treatment of hyperthyroidism with a combination of methimazole and cholestyramine,' by M. Mercado, et al, from the 1996 issue, volume 81 of the `Journal of Clinical Endocrinology and Metabolism.'

  • ALZA to acquire SEQUUS.  // Medical Marketing & Media;Nov98, Vol. 33 Issue 11, p28 

    Reports on the merger agreement between ALZA and SEQUUS Pharmaceutical Group. Impact of the transaction on ALZA; Terms of the agreement; Aggregate transaction value.

  • AIA Appoints Former Chief Of Staff For Rep. Gephardt, As Vice President, Federal Affairs.  // Insurance Advocate;1/13/2003, Vol. 114 Issue 2, p20 

    Reports on the appointment of Moses Mercado as vice president for federal affairs by the American Insurance Association. Career history of Mercado; Responsibilities of Mercado; Business philosophy of Mercado.

  • Company Overview.  // ALZA Corporation SWOT Analysis;Jun2007, p4 

    An overview of Alza Corp., a provider of drug delivery solutions, is presented. Data is included on various commercialized products wherein Alza's technologies have been incorporated, as well as on various fields wherein Alza has its own expertise.

  • Hydromorphone HC1 Extended-Release Tablets (Exalgo) CII. Elliott, William T.; Chan, James // Internal Medicine Alert;4/15/2010, Vol. 32 Issue 7, p52 

    The article evaluates the Hydromorphone hydrochloride (HCI) tablets from Alza Corp.

  • Alza to acquire Sequus Pharmaceuticals.  // Chemical Market Reporter;10/12/98, Vol. 254 Issue 15, p28 

    Announces the agreement of drug delivery and pharmaceuticals company, Alza Corp. to acquire Sequus Pharmaceuticals Inc. in a stock swap valued at $580 million. Significance of the move for Alza.

  • Legal Briefs.  // HR Specialist: Pennsylvania Employment Law;Aug2012, Vol. 7 Issue 8, p3 

    The article offers legal briefs in 2012 such as the EEOC v. U.S. Steel, et al. over wrong forced medical examinations on disabled employees without a job-related reason and the Mercado v. Donahoe over minor disagreements that turned into all-out arguments.

  • Life after Syntex. Zaffaroni, Alejandro // Chemical Heritage;Summer2005, Vol. 23 Issue 2, p9 

    Recalls a work experience and life after working for Syntex. Background on the foundation of Alza Corp. in 1968; Acquisition of Alza by Johnson & Johnson in 1981; Information on the possibility of cigarette as a drug-delivery device.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics